Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T82262 | Target Info | |||
Target Name | Calmodulin-dependent kinase II (CAMKK2) | ||||
Synonyms | KIAA0787; Calcium/calmodulin-dependent protein kinase kinase beta; Calcium/calmodulin-dependent protein kinase kinase 2; CaMKK beta; CaMKK 2; CaM-kinase kinase beta; CaM-kinase kinase 2; CaM-KK beta; CaM-KK 2; CAMKKB | ||||
Target Type | Patented-recorded Target | ||||
Gene Name | CAMKK2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | L-serine-O-phosphate | Ligand Info | |||
Canonical SMILES | C(C(C(=O)O)N)OP(=O)(O)O | ||||
InChI | 1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1 | ||||
InChIKey | BZQFBWGGLXLEPQ-REOHCLBHSA-N | ||||
PubChem Compound ID | 68841 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6CMJ Human CAMKK2 with GSK650393 | ||||||
Method | X-ray diffraction | Resolution | 2.40 Å | Mutation | No | [1] |
PDB Sequence |
QLDQYTLKDE
170 IGKGSYGVVK180 LAYNENDNTY190 YAMKVLSKKK200 LIRQAGGCIQ225 PRGPIEQVYQ 235 EIAILKKLDH245 PNVVKLVEVL255 DDPNEDHLYM265 VFELVNQGPV275 MEVPTLKPLS 285 EDQARFYFQD295 LIKGIEYLHY305 QKIIHRDIKP315 SNLLVGEDGH325 IKIADFGVSN 335 EFKGSDALLN346 TVGTPAFMAP356 ESLSETRKIF366 SGKALDVWAM376 GVTLYCFVFG 386 QCPFMDERIM396 CLHKIKSQAL407 EFPDQPDIAE417 DLKDLITRML427 DKNPESRIVV 437 PEIKLHPWVT447 RHGAEPLPSE457 DENCL
|
|||||
|
||||||
PDB ID: 6Y4K Crystal structure of human 14-3-3 gamma in complex with CaMKK2 14-3-3 binding motif Ser100 and Fusicoccin A | ||||||
Method | X-ray diffraction | Resolution | 3.00 Å | Mutation | No | [2] |
PDB Sequence |
RKLLQER
|
|||||
|
||||||
PDB ID: 6Y6B Crystal structure of human 14-3-3 gamma in complex with CaMKK2 14-3-3 binding motif Ser100 and 16-OMe-Fusicoccin H | ||||||
Method | X-ray diffraction | Resolution | 3.08 Å | Mutation | No | [2] |
PDB Sequence |
KLLQER
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model. Bioorg Med Chem Lett. 2018 Jun 1;28(10):1958-1963. | ||||
REF 2 | Stabilization of Protein-Protein Interactions between CaMKK2 and 14-3-3 by Fusicoccins. ACS Chem Biol. 2020 Nov 20;15(11):3060-3071. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.